Article
Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: detection of three novel malignant hyperthermia alleles.
Clinical chemistry - 1 May 2003
Tammaro Angela, Bracco Adele, Cozzolino Santolo, Esposito Maria, Di Martino Antonietta, Savoia Gennaro, Zeuli Laura, Piluso Giulio, Aurino Stefania, Nigro Vincenzo
Abstract excerpt
BACKGROUND: Malignant hyperthermia (MH) is a fatal autosomal dominant pharmacogenetic disorder characterized by skeletal muscle hypertonicity that causes a sudden increase in body temperature after exposure to common anesthetic agents. The disease is genetically heterogeneous, with mutations in the gene encoding the skeletal muscle ryanodine receptor (RYR1) at 19q13.1 accounting for up to 80% of the cases. To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
